Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05746624 · ClinicalTrials.gov registry record

Procedural Motor Memory in Long COVID-19

A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

Completed
Registry status
333
Enrollment target

NCT05746624 is a clinical trial that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 333 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05746624 has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).

COMPLETED
Registry status
333 participants
Enrollment target

Study Summary

Background: Most people who get COVID-19 seem to recover with no long-term effects. However, some people who recover from acute COVID-19 infections report lingering symptoms. This is called long COVID. Many people with long COVID report symptoms related to the nervous system; these can include problems with fatigue, speech, and memory. Objective: To test motor memory in people with long COVID, compared to healthy volunteers. Eligibility: People aged 18 to 90 years who are also enrolled in study protocol 000089. Healthy adults are also needed. Design: Participants will be screened by telephone. They will confirm they are able to type without discomfort using their nondominant hand. They will confirm they have access to a computer connected to the internet. All study tasks will be done online. Participants will complete 2 tasks in 2 days. Participants will be sent a link to a website. The website will give them instructions. They will place the fingers of their nondominant hand over 4 numbers on the keyboard and type a sequence (eg, 4-1-3-2-4). They will type this sequence as often as they can in 10 seconds. Then they will rest for 10 seconds before repeating the task. They will repeat this pattern for 15 minutes. After they finish the typing task, participants will take a 10-minute questionnaire. They will answer questions about their experiences with COVID-19 and memory issues; they will say which hand they use for tasks such as brushing their teeth or throwing a ball. Participants will get a notice to repeat the typing task 22 hours after they finish the first one. They should complete the second task within 28 hours....

Interventions

  • BEHAVIORAL keypresses

Trial Details

FieldValue
Enrollment Target 333 participants
Start Date 2021-11-15
Est. Completion 2022-03-17

What the Registry Record Tells You About NCT05746624

The ClinicalTrials.gov registry entry for NCT05746624 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which keypresses is the first listed.

NCT05746624 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05746624 about?

NCT05746624 is a clinical study titled "Procedural Motor Memory in Long COVID-19". Background: Most people who get COVID-19 seem to recover with no long-term effects. However, some people who recover from acute COVID-19 infections report lingering symptoms. This is called long COVID. Many people with long COVID report symptoms related to the nervous system; these can include prob...

What is the current status of trial NCT05746624?

This trial is currently completed. The enrollment target is 333 participants. The study started on 2021-11-15. Estimated completion is 2022-03-17.

What interventions are being tested in trial NCT05746624?

The interventions under investigation include: keypresses (BEHAVIORAL).

Who is sponsoring clinical trial NCT05746624?

This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.